Terumo Blood and Cell Technologies Supports New Imara Sickle Cell Framework
NAIROBI, Kenya / KAMPALA, Uganda, June 19, 2026 African health leaders, government officials, clinicians, patient advocates, and international partners...
.Gov for New Therapy
FDA Cracks Down on Illegal Tobacco Product Sales
SILVER SPRING, Md., May 20, 2026 The U.S. Food and Drug Administration (FDA) has intensified its enforcement efforts against...
Taiho Oncology Wins FDA Approval for INQOVI Combo
PRINCETON, N.J. and TOKYO, May 13, 2026 Taiho Oncology and Taiho Pharmaceutical announced that the U.S. Food and Drug...
Lupin Wins U.S. FDA Approval for Famotidine Injection
MUMBAI, India and NAPLES, Fla., May 13, 2026 Global pharmaceutical company Lupin Limited announced that it has received approval...
FDA Expands Drug Repurposing Initiative for Rare Diseases
WASHINGTON, May 11, 2026 The U.S. Food and Drug Administration announced a new initiative aimed at accelerating drug repurposing...
FDA Releases Pregnancy Safety Guidance for Drugs and Biologics
WASHINGTON, D.C., United States – May 8, 2026 The U.S. Food and Drug Administration announced the release of a...
FDA Approves Bizengri for Rare Cholangiocarcinoma
SILVER SPRING, Maryland, May 8, 2026 The U.S. Food and Drug Administration (FDA) has approved Bizengri (zenocutuzumab-zbco) for the...
Zentiva Appeals EU Wastewater Directive Impact on Pharma
PRAGUE / BRUSSELS, April 27, 2026 Zentiva has filed an appeal before the Court of Justice of the European...
FDA Fast-Tracks Psychedelic Therapies for Mental Illness
WASHINGTON, D.C., April 24, 2026 The U.S. Food and Drug Administration has announced a series of accelerated regulatory actions...
Vanda Urges FDA to Reject Extended Drug Review Timelines
WASHINGTON, April 9, 2026 Vanda Pharmaceuticals Inc. has publicly called on the U.S. Food and Drug Administration (FDA) to...